|
The document is a final report from 3M Company detailing a cross-sectional analysis of serum levels of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) among employees participating in the 2000 medical surveillance program at their Antwerp and Decatur fluorochemical manufacturing plants, focusing on potential correlations with clinical chemistry, thyroid hormone, hemat
|
2001 |
AR226-1047
|
nNNk2NzEX2Y9gdgzNz9j458o8 |
122 |